Results 141 to 150 of about 243,517 (196)

Sacubitril/valsartan is associated with improvements in quality of life in adult congenital heart disease patients with systemic right ventricular failure. [PDF]

Open Heart
Neijenhuis RML, Nederend M, van Groningen AE, Jongbloed MRM, Vliegen HW, Jukema JW, Kiès P, Egorova AD.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Adult Congenital Heart Disease

3D Echocardiography, 2020
Congenital heart disease remains the most common congenital disorder in newborns and affects 0.4%–1% of the population. The spectrum of defects is wide and ranges from small and hemodynamically insignificant lesions to very complex conditions, such as functionally univentricular hearts with a variety of associated lesions.
Pastora Gallego, Silvia Montserrat
semanticscholar   +3 more sources

Adult Congenital Heart Disease

Circulation
Abstract Congenital heart disease (CHD) is common, accounting for approximately 1% of live births. Advances in paediatric cardiology and surgical care mean that the majority of those with moderate to severely complex CHD now survive to adulthood. These individuals require lifelong surveillance and are unfortunately prone to developing
Erik Su, Saul Flores
  +8 more sources

Micra pacemaker in adult congenital heart disease patients: A case series

Cardiovascular Electrophysiology, 2022
Implantation of transvenous endocardial or epicardial pacemakers presents specific challenges in adult congenital heart disease (ACHD) patients. Micra leadless permanent pacemakers (Micra PPM) may overcome some of these difficulties.
P. Bassareo, Kevin P. Walsh
semanticscholar   +1 more source

Adult congenital heart disease

Pediatric Anesthesia, 2011
SummaryFor a decade now, it has been recognized that optimal management of adult congenital heart disease (ACHD) requires a skilled multidisciplinary team. The size and complexity of the population of adults with congenital heart disease (CHD) are increasing.
G.P. Diller, A. Kempny, H. Baumgartner
openaire   +3 more sources

Adult congenital heart disease update

Current Problems in Pediatric and Adolescent Health Care, 2023
In this issue of Current Problems in Pediatric and Adolescent Health Care, we discuss the field of Adult Congenital Heart Disease (ACHD) is addressed. Following a general overview of the subject provided, a more in-depth and focused review of the field provided by Dr.
openaire   +2 more sources

Congenital heart disease in adults

BMJ, 2016
#### What you need to know Heart disease is the most common birth defect, affecting nine in 1000 babies born in the United Kingdom. The spectrum of the underlying lesions ranges from a simple septal defect to more complex structural abnormalities. Most of those born with cardiac defects lead active lives and survive well into late adulthood.
Bejal, Pandya, Shay, Cullen, Fiona, Walker   +2 more
openaire   +2 more sources

Heart Failure in Adult Congenital Heart Disease

Cardiology Clinics, 2020
As the population of adult congenital heart disease patients ages and grows, so too does the burden of heart failure in this population. Despite the advances in medical and surgical therapies over the last decades, heart failure in adult congenital heart disease remains a formidable complication with high morbidity and mortality. This review focuses on
Luke J, Burchill, Melissa G Y, Lee, Vidang P, Nguyen, Karen K, Stout   +3 more
openaire   +2 more sources

Congenital heart disease in adults

The American Journal of Surgery, 1966
Abstract A series of forty-one patients who have attained adulthood despite significant hemodynamic congenital heart defects is presented. Thirty-four have undergone open heart methods and seven, closed heart procedures. Only one death occurred in the series, a mortality of 2.4 per cent. Two patients had complications but survived.
W D, Johnson, R, Dawes, J, Walker, C, Leagus, D, Lepley   +4 more
openaire   +2 more sources